Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy-Reference-Cited by-同舟云学术

Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy

Published:2024-02-14 Issue:6 Volume:20 Page:623-633
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Dupont Christophe¹,Burks A. Wesley²,Fleischer David M.³,Bee Katharine J.⁴,Chainani Sarita⁴,Sampson Hugh A.⁴⁵

Affiliation:

1. Pediatric Gastroenterology Department, Marcel Sembat Clinic, Ramsay Group, Boulogne Billancourt, France

2. Division of Pediatric Allergy and Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA

3. Children’s Hospital Colorado, Section of Allergy and Immunology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA

4. DBV Technologies, Basking Ridge, NJ, United States

5. Department of Pediatrics, Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Funder

DBV Technologies

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2024.2315221

Reference52 articles.

1. Peanut allergy prevalence among school-age children in a US cohort not selected for any disease

2. Severity of peanut allergy and the unmet gaps in care: a call to action;Lieberman JA.;Am J Manag Care,2018

3. The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States

4. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up

5. Natural history of peanut allergy and predictors of resolution in the first 4 years of life: A population-based assessment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Food allergy yardstick;Annals of Allergy, Asthma & Immunology;2024-08